retatrutide clinical trial Looking forward to when #retatrutide's Phase 3 results will become available. There are are 4 planned TRIUMPH trials investigating retatrutide's efficacy in treating obesity and its complications: #type2diabetes #cardiovascular disease Medscape | Retatrutide, Eli Lilly's

Methods A multidisciplinary expert panel comprising three endocrinologists, two nephrologists, two primary care physicians (PCPs), two cardiologists, two internists and one DNE, all of them with clinical expertise in the management of people with T2D or obesity with GLP-1 RA-based therapies, convened across virtual meetings to reach a consensus

BMO noted the dysesthesia signal and said the firm will be watching for it in readouts to come and for more detailed data from the TRIUMPH-4 trial

All because the peptide in your syringe was not what you thought it was

2026 has seen a 24% surge in interest in GLP-1 medications and peptides